Skip to Content

Baird Mid Cap Growth Investor BMDSX

Medalist Rating as of | See Baird Investment Hub
  • NAV / 1-Day Return 21.79  /  −0.18 %
  • Total Assets 2.3 Bil
  • Adj. Expense Ratio
    1.070%
  • Expense Ratio 1.070%
  • Distribution Fee Level Above Average
  • Share Class Type No Load
  • Category Mid-Cap Growth
  • Investment Style Mid Growth
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield
  • Turnover 42%

USD | NAV as of Apr 25, 2024 | 1-Day Return as of Apr 25, 2024, 10:10 PM GMT+0

Morningstar’s Analysis BMDSX

Will BMDSX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Typically outperforms in down markets.

Senior Analyst Stephen Welch

Stephen Welch

Senior Analyst

Summary

Veteran managers steer Baird Mid Cap Growth using a quality-oriented, time-tested approach. It earns a Morningstar Medalist Rating of Bronze across both share classes.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BMDSX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 24.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

DexCom Inc

3.21 83.4 Mil
Healthcare

CDW Corp

2.61 67.8 Mil
Technology

IDEXX Laboratories Inc

2.48 64.5 Mil
Healthcare

Icon PLC

2.45 63.6 Mil
Healthcare

Heico Corp

2.40 62.3 Mil
Industrials

Veeva Systems Inc Class A

2.34 60.8 Mil
Healthcare

Watsco Inc Class A

2.30 59.6 Mil
Industrials

Copart Inc

2.29 59.4 Mil
Industrials

Globant SA

2.23 57.8 Mil
Technology

Floor & Decor Holdings Inc Class A

2.18 56.6 Mil
Consumer Cyclical